Amgen, Horizon Say FTC Merger Challenge 'Defies Logic'
By Bryan Koenig · August 22, 2023, 9:01 PM EDT
Amgen and Horizon Therapeutics urged an Illinois federal judge not to let the Federal Trade Commission block their planned $27.8 billion merger, arguing in a brief unsealed Tuesday that FTC fears...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login